Novartis wins 1st place at the SAMS Europe Award 2017 with “Cloud SAM for Salesforce”

License Control for Salesforce from Aspera enables cloud cost optimization.
License Control for Salesforce from Aspera enables cloud cost optimization.
SAN FRANCISCO, CA — (Marketwire) — 09/26/11 — Today Health 2.0 announced the launch of the Novartis CardioEngagement Challenge which asks multi-disciplinary teams of developers to create an interactive solution that will enable patients to better manage their cardiovascular health through a customizable, user-friendly interface.The Novartis CardioEngagement Challenge is part of a broader, bold new program called the Health 2.0 Developer Challenge that is designed to spur innovations in the
One of XClinical’s customers, the Munich-based CRO OSE Oncology Services Europe S.a.r.l., has just started a large clinical trial for one of Europe’s premier pharmaceutical companies.